AnPac Bio-Medical Science Co. Ltd.

0.2885-0.0063-2.14%Vol 357.51K1Y Perf -92.48%
Jun 24th, 2022 16:00 DELAYED
BID0.2830 ASK0.2900
Open0.2901 Previous Close0.2948
Pre-Market- After-Market0.29
 - -  0.00 -1.01%
Target Price
8.00 
Analyst Rating
— — 0.00
Potential %
2.67K 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12 mo.
-/-/- 
Value Ranking
     23.99
Insiders Value % 3/6/12 mo.
-/-/- 
Growth Ranking
 —    -
Insiders Shares Cnt. % 3/6/12 mo.
-/-/- 
Income Ranking
 —    -
Price Range Ratio 52W %
1.99 
Earnings Rating
Market Cap7.28M 
Earnings Date
26th May 2022
Alpha-0.11 Standard Deviation0.23
Beta1.57 

Today's Price Range

0.28100.3100

52W Range

0.20254.52

Summary:

Sell

Technical Indicators: Neutral
Moving Averages: Strong Sell
Performance
1 Week
-1.90%
1 Month
2.30%
3 Months
-38.22%
6 Months
-72.52%
1 Year
-92.48%
3 Years
-
5 Years
-
10 Years
-

TickerPriceChg.Chg.%
ANPC0.2885-0.0063-2.14
AAPL141.663.39002.45
GOOG2 370.76117.07005.19
MSFT267.708.84003.41
XOM86.901.69001.98
WFC40.762.86007.55
JNJ182.292.63001.46
FB196.640.99000.51
GE67.083.01004.70
JPM117.323.40002.98
Financial StrengthValueIndustryS&P 500US Markets
0.10
0.40
0.47
2.30
-27.70
Leverage Ratio 11.50
ProfitabilityValueIndustryS&P 500US Markets
67.90
-581.10
-581.10
-692.90
-
RevenueValueIndustryS&P 500US Markets
2.81M
0.25
-
-
Earnings HistoryEstimateReportedSurprise %
Q02 2021--0.34-
Q01 2021--0.37-
----
----
----
----
----
----
Earnings Per EndEstimateRevision %Trend
----
----
----
----
Next Report Date-
Estimated EPS Next Report-
Estimates Count-
EPS Growth Next 5 Years %-
Volume Overview
Volume357.51K
Shares Outstanding25.22K
Shares Float1.55M
Trades Count746
Dollar Volume105.85K
Avg. Volume847.80K
Avg. Weekly Volume568.70K
Avg. Monthly Volume953.90K
Avg. Quarterly Volume1.02M

AnPac Bio-Medical Science Co. Ltd. (NASDAQ: ANPC) stock closed at 0.2885 per share at the end of the most recent trading day (a -2.14% change compared to the prior day closing price) with a volume of 357.51K shares and market capitalization of 7.28M. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Biotechnology industry, Healthcare sector and employs 111 people. AnPac Bio-Medical Science Co. Ltd. CEO is Chris Chang Yu.

The one-year performance of AnPac Bio-Medical Science Co. Ltd. stock is -92.48%, while year-to-date (YTD) performance is -76.35%. ANPC stock has a five-year performance of %. Its 52-week range is between 0.2025 and 4.52, which gives ANPC stock a 52-week price range ratio of 1.99%

AnPac Bio-Medical Science Co. Ltd. currently has a PE ratio of -0.30, a price-to-book (PB) ratio of 6.09, a price-to-sale (PS) ratio of 1.17, a price to cashflow ratio of -, a PEG ratio of 2.32, a ROA of -163.49%, a ROC of -307.21% and a ROE of -1 254.10%. The company’s profit margin is -%, its EBITDA margin is -581.10%, and its revenue ttm is $2.81 Million , which makes it $0.25 revenue per share.

Of the last four earnings reports from AnPac Bio-Medical Science Co. Ltd., there were 0 positive earnings surprise and 0 negative earnings surprise. The company has EPS estimate of $0.00 for the next earnings report. AnPac Bio-Medical Science Co. Ltd.’s next earnings report date is -.

The consensus rating of Wall Street analysts for AnPac Bio-Medical Science Co. Ltd. is (), with a target price of $, which is 0.00% compared to the current price. The earnings rating for AnPac Bio-Medical Science Co. Ltd. stock is (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

AnPac Bio-Medical Science Co. Ltd. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

AnPac Bio-Medical Science Co. Ltd. has a Sell technical analysis rating based on Technical Indicators (ADX : 31.70, ATR14 : 0.04, CCI20 : -17.38, Chaikin Money Flow : -0.36, MACD : -0.01, Money Flow Index : 36.75, ROC : -5.66, RSI : 45.58, STOCH (14,3) : 15.09, STOCH RSI : 0.37, UO : 40.42, Williams %R : -84.91), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of AnPac Bio-Medical Science Co. Ltd. in the last 12-months were:

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
0
0
0
Moderate Buy
0
0
0
Hold
0
0
0
Moderate Sell
0
0
0
Strong Sell
0
0
0
Summary Rating-
0.00
-
0.00
-
0.00

AnPac Bio-Medical Science Co. Ltd.

AnPac Bio-Medical Science Co Ltd is a biotechnology company. It focuses on early cancer screening and detection. The company markets and sells a multi-cancer screening and detection test that uses its innovative, patented CDA technology and its proprietary CDA device. In addition to early cancer screening and detection, its CDA technology has demonstrated potential to assist physicians in cancer diagnosis, prognosis and recurrence.

CEO: Chris Chang Yu

Telephone: +86 57820516666

Address: 801 Bixing Street, Lishui 323006, , CN

Number of employees: 111

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

61%39%

Bearish Bullish

70%30%

Bearish Bullish

70%30%

News

Stocktwits